Key points are not available for this paper at this time.
Hyper-CVAD therapy is superior to our previous regimens and should be compared with established regimens in adult ALL.
Kantarjian et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: